Order: In the Matter of Fraser Macdougall et al.

IN THE MATTER OF
FRASER MACDOUGALL and CHRIS BOGART

-and-

IN THE MATTER OF
TRYP THERAPEUTICS INC.

Timothy Moseley, Vice-Chair and Chair of the Panel

File No. 2022-4

March 10, 2022

ORDER

(Subsection 3.5(2) of the Securities Act, RSO 1990, c S.5)

WHEREAS the Ontario Securities Commission held a hearing in writing to consider a Motion brought by Fraser MacDougall and Chris Bogart requesting that their Application dated March 4, 2022, relating to a proposed financing for Tryp Therapeutics Inc., be heard in a joint hearing with the British Columbia Securities Commission (BCSC);

ON READING the Applicants’ Motion and supporting materials (including the Affidavit of Kayleigh Hansen dated March 4, 2022), the submissions of Staff of the Commission, and the submissions of the Executive Director of the BCSC, and considering that Tryp Therapeutics Inc. does not oppose the making of this order;

IT IS ORDERED, for reasons to follow, that the Application will be heard jointly with the BCSC, pursuant to subsection 3.5(2) of the Securities Act and Rule 30 of the Commission’s Rules of Procedure and Forms, (2019) 42 OSCB 9714.

“Timothy Moseley”
Timothy Moseley